Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

SMIN

iShares MSCI India Small Cap ETF (SMIN)

Rating:59Neutral
Price Target:$72.00â–²(1.22% Upside)

SMIN, the iShares MSCI India Small Cap ETF, has a solid but not top-tier overall rating, reflecting a mix of strong growth stories and valuation or risk concerns among its holdings. High-quality names like Coforge, Embassy Office Parks REIT, and IPCA Laboratories support the fund’s rating with robust financial performance and generally positive momentum, while weaker or more challenged holdings such as Glenmark Pharmaceuticals and leveraged names like 360 One Wam limit the upside. The main risk factor is that many holdings show signs of overvaluation or overbought technical conditions, which could make the fund more sensitive to market pullbacks.

Positive Factors
Strong Performance Among Several Top HoldingsMany of the largest positions, such as Sona BLW Precision Forgings and APAR Industries, have shown strong gains, helping support the fund despite recent weakness.
Broad Small-Cap Exposure Within IndiaThe ETF holds a wide range of Indian small-cap companies, which can provide diversified exposure to the country’s growth potential beyond its largest firms.
Meaningful Asset SizeThe fund’s sizable assets under management suggest it is established and has attracted enough investor interest to support ongoing operations and liquidity.
Negative Factors
Recent Weak Overall PerformanceThe ETF has shown weak returns over the past month, three months, and year to date, indicating recent challenges for Indian small-cap stocks.
High Single-Country ConcentrationAlmost all of the fund’s holdings are in India, so investors are heavily exposed to economic and market risks specific to that country.
Relatively High Expense RatioThe fund’s fee is on the higher side for an ETF, which means more of the returns are eaten up by costs over time.

SMIN vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%SPY+14.55%SMIN-0.94%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
740.15M
Region
Asia-Pacific
Expense Ratio
0.74%
Beta
0.66
Issuer
iShares
Inception Date
Feb 08, 2012
Dividend Yield
1.98%
Asset Class
Equity
Index Tracked
MSCI India Small Cap

SMIN Summary

SMIN is the iShares MSCI India Small Cap ETF, which follows the MSCI India Small Cap Index. It invests in many smaller Indian companies across different industries, giving you broad exposure to India’s growing economy. These are not the big household names, but rising businesses like Glenmark Pharmaceuticals and Max Financial Services that may have room to grow. Someone might invest in SMIN to seek long-term growth and add international diversification to their portfolio. However, small-cap stocks in emerging markets can be very volatile, so the value of this ETF can go up and down sharply.

How much will it cost me?

This ETF has an expense ratio of 0.74%, which means you’ll pay about $7.40 per year for every $1,000 invested. That’s higher than the average ETF because it focuses on a more specialized, small-cap India market and is more complex to manage than broad, passive index funds.

What would affect this ETF?

SMIN could benefit if India’s economy continues to grow, small local companies gain from rising consumer demand and infrastructure spending, and sectors like technology, financial services, and pharmaceuticals—represented by holdings such as Coforge, Max Financial Services, and Glenmark—keep expanding. On the other hand, higher interest rates, weaker economic growth in India, currency swings, or new regulations affecting small businesses or specific industries could hurt these smaller, more volatile companies and weigh on the ETF’s performance.

SMIN Top 10 Holdings

SMIN is riding a wave of India’s fast-growing small caps, with names like Ather Energy and APAR Industries providing much of the spark as their shares have been rising strongly this year. Coforge and Navin Fluorine add to the momentum, reflecting steady strength in tech and specialty chemicals. On the flip side, Max Financial Services has been lagging, while Embassy Office Parks REIT and Glenmark Pharmaceuticals are more mixed, acting as mild brakes on performance. Overall, the fund is India-focused and tilted toward growth-oriented industrial, tech, and specialty manufacturing stories.

SMIN top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
IN:COFORGEIN:COFORGECoforge Limited1.95%$14.34MINR 897.65B11.88%73Outperform
IN:SONACOMSIN:SONACOMSSona BLW Precision Forgings Ltd.1.19%$8.78MINR 573.91B87.71%74Outperform
IN:GLENMARKIN:GLENMARKGlenmark Pharmaceuticals Limited1.11%$8.18MINR 745.92B40.85%53Neutral
IN:EMBASSYIN:EMBASSYEmbassy Office Parks REIT1.08%$7.93MINR 401.91B0.56%76Outperform
IN:MFSLIN:MFSLMax Financial Services Limited1.08%$7.96MINR 482.82B-18.12%59Neutral
IN:RADICOIN:RADICORadico Khaitan Limited1.01%$7.46MINR 616.22B44.21%65Neutral
IN:NAVINFLUORIN:NAVINFLUORNavin Fluorine International Limited0.99%$7.32MINR 514.63B66.26%64Neutral
IN:ATHERENERGIN:ATHERENERGAther Energy Limited0.94%$6.93MINR 770.75B203.67%――
IN:360ONEIN:360ONE360 One Wam Limited0.82%$6.05MINR 479.71B8.39%65Neutral
IN:IPCALABIN:IPCALABIPCA Laboratories Limited0.78%$5.77MINR 478.20B44.71%74Outperform

SMIN Technical Analysis

Technical Analysis SentimentPositive
Last Price71.13

Price Trends

50DMA69.12Positive
100DMA69.88Positive
200DMA67.75Positive

Market Momentum

MACD0.63Negative
RSI62.66Neutral
STOCH97.25Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Positive. The current price of 71.13 is above the 20-day moving average (MA) of 68.43, above the 50-day MA of 69.12, and above the 200-day MA of 67.75, indicating a bullish trend. The MACD of 0.63 indicates Negative momentum. The RSI at 62.66 is Neutral, neither overbought nor oversold. The STOCH value of 97.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMIN.

SMIN Peer Comparison

Comparison Results

SMIN against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
SMINSMIN$71.13$72.00(1.22% Upside)$740.15M0.74%59Neutral
INDAINDA$51.45$57.18(11.14% Upside)$6.85B0.61%66Neutral
FLINFLIN$36.74$40.65(10.64% Upside)$2.79B0.19%65Neutral
INDYINDY$45.79$51.55(12.59% Upside)$598.81M0.65%67Neutral
GINDGIND$25.54―$171.45M0.75%56Neutral
NFTYNFTY$55.53$61.24(10.29% Upside)$109.66M0.80%64Neutral

Performance Comparison

-20%-15%-10%-5%0%SMININDAFLININDYGINDNFTYDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SMIN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SMINiShares MSCI India Small Cap ETF71.13-1.25-1.72%
INDAiShares MSCI India ETF51.45-3.20-5.86%
FLINFranklin FTSE India ETF36.74-2.25-5.78%
INDYiShares India 50 ETF45.79-3.45-7.01%
GINDGoldman Sachs India Equity ETF25.54-1.08-4.07%
NFTYFirst Trust India NIFTY 50 Equal Weight ETF55.52-2.62-4.50%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.